Literature DB >> 2024811

Pulmonary mechanics in lymphangioleiomyomatosis.

C D Burger1, R E Hyatt, B A Staats.   

Abstract

Standard pulmonary function and mechanics studies were done in eight female patients with lymphangioleiomyomatosis diagnosed by open-lung biopsy. Five patients were studied before hormone treatment. The mean age of the patients was 40 +/- 3 (SEM) years. Two of the eight had a smoking history of 10 pack-years or more, but all had quit smoking several years before evaluation. There was a trend toward increased total lung capacity (114 +/- 7% expressed as mean of percentage predicted +/- SEM) and increased residual volume (207 +/- 24%). Of the eight patients seven had expiratory obstruction as evidenced by the reduced forced expiratory volume in 1 s/forced vital capacity ratio [( FEV1/FVC] 61 +/- 6%). Steady-state diffusing capacity for carbon monoxide was reduced in seven of the patients (57 +/- 12%). Pulmonary mechanics studies performed in a body plethysmograph revealed a modest reduction in retractive force both at total lung capacity and at 90% total lung capacity (67 +/- 10 and 59 +/- 9%, respectively). Static compliance tended to be increased (128 +/- 19%). Pulmonary flow resistance was markedly elevated (266 +/- 46%). Maximal flow-static recoll curves revealed that in the seven patients with expiratory obstruction the cause was predominantly airway narrowing rather than loss of lung elastic forces. We conclude that in this group of patients with lymphangioleiomyomatosis there was no evidence for significant restriction. Although there was some decrease in retractive force consistent with emphysema, expiratory flows were reduced predominantly because of airway narrowing or obstruction rather than loss of pulmonary elastic recoil forces.

Entities:  

Mesh:

Year:  1991        PMID: 2024811     DOI: 10.1164/ajrccm/143.5_Pt_1.1030

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  8 in total

Review 1.  Rare diseases. 1. Lymphangioleiomyomatosis: clinical features, management and basic mechanisms.

Authors:  S Johnson
Journal:  Thorax       Date:  1999-03       Impact factor: 9.139

Review 2.  Lymphangioleiomyomatosis.

Authors:  Francis X McCormack
Journal:  MedGenMed       Date:  2006-01-18

3.  Clinical experience of lymphangioleiomyomatosis in the UK.

Authors:  S R Johnson; A E Tattersfield
Journal:  Thorax       Date:  2000-12       Impact factor: 9.139

4.  Reversible airflow obstruction in lymphangioleiomyomatosis.

Authors:  Angelo M Taveira-DaSilva; Wendy K Steagall; Antoinette Rabel; Olanda Hathaway; Sergio Harari; Roberto Cassandro; Mario Stylianou; Joel Moss
Journal:  Chest       Date:  2009-05-15       Impact factor: 9.410

5.  EPIDEMIOLOGY, PATHOGENESIS and DIAGNOSIS of LYMPHANGIOLEIOMYOMATOSIS.

Authors:  Angelo M Taveira-DaSilva; Joel Moss
Journal:  Expert Opin Orphan Drugs       Date:  2016-03-07       Impact factor: 0.694

6.  Ultra-Small Lung Cysts Impair Diffusion Without Obstructing Air Flow in Lymphangioleiomyomatosis.

Authors:  Brianna P Matthew; Amir M Hasani; Yun-Ching Chen; Mehdi Pirooznia; Mario Stylianou; Shirley F Rollison; Tania R Machado; Nora M Quade; Amanda M Jones; Patricia Julien-Williams; Angelo Taveira-DaSilva; Marcus Y Chen; Joel Moss; Han Wen
Journal:  Chest       Date:  2021-02-05       Impact factor: 9.410

Review 7.  Clinical features, epidemiology, and therapy of lymphangioleiomyomatosis.

Authors:  Angelo M Taveira-DaSilva; Joel Moss
Journal:  Clin Epidemiol       Date:  2015-04-07       Impact factor: 4.790

8.  Quantitative analysis of airway obstruction in lymphangioleiomyomatosis.

Authors:  Stijn E Verleden; Arno Vanstapel; Laurens De Sadeleer; Birgit Weynand; Matthieu Boone; Erik Verbeken; Davide Piloni; Dirk Van Raemdonck; Maximilian Ackermann; Danny D Jonigk; Johny Verschakelen; Wim A Wuyts
Journal:  Eur Respir J       Date:  2020-07-02       Impact factor: 16.671

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.